Literature DB >> 23770318

A computational framework for the analysis of peptide microarray antibody binding data with application to HIV vaccine profiling.

Greg C Imholte1, Renan Sauteraud, Bette Korber, Robert T Bailer, Ellen T Turk, Xiaoying Shen, Georgia D Tomaras, John R Mascola, Richard A Koup, David C Montefiori, Raphael Gottardo.   

Abstract

We present an integrated analytical method for analyzing peptide microarray antibody binding data, from normalization through subject-specific positivity calls and data integration and visualization. Current techniques for the normalization of such data sets do not account for non-specific binding activity. A novel normalization technique based on peptide sequence information quickly and effectively reduced systematic biases. We also employed a sliding mean window technique that borrows strength from peptides sharing similar sequences, resulting in reduced signal variability. A smoothed signal aided in the detection of weak antibody binding hotspots. A new principled FDR method of setting positivity thresholds struck a balance between sensitivity and specificity. In addition, we demonstrate the utility and importance of using baseline control measurements when making subject-specific positivity calls. Data sets from two human clinical trials of candidate HIV-1 vaccines were used to validate the effectiveness of our overall computational framework.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibodies; Normalization; Peptide microarrays; Positivity calls; Software; Visualization

Mesh:

Substances:

Year:  2013        PMID: 23770318      PMCID: PMC3999921          DOI: 10.1016/j.jim.2013.06.001

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  25 in total

1.  Analysis of variance for gene expression microarray data.

Authors:  M K Kerr; M Martin; G A Churchill
Journal:  J Comput Biol       Date:  2000       Impact factor: 1.479

2.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.

Authors:  B M Bolstad; R A Irizarry; M Astrand; T P Speed
Journal:  Bioinformatics       Date:  2003-01-22       Impact factor: 6.937

3.  Validation of peptide epitope microarray experiments and extraction of quality data.

Authors:  Tatjana Nahtman; Alexander Jernberg; Shahnaz Mahdavifar; Johannes Zerweck; Mike Schutkowski; Markus Maeurer; Marie Reilly
Journal:  J Immunol Methods       Date:  2007-08-13       Impact factor: 2.303

Review 4.  Visualisation and pre-processing of peptide microarray data.

Authors:  Marie Reilly; Davide Valentini
Journal:  Methods Mol Biol       Date:  2009

5.  Kinome profiling of chondrosarcoma reveals SRC-pathway activity and dasatinib as option for treatment.

Authors:  Yvonne M Schrage; Inge H Briaire-de Bruijn; Noel F C C de Miranda; Jolieke van Oosterwijk; Antonie H M Taminiau; Tom van Wezel; Pancras C W Hogendoorn; Judith V M G Bovée
Journal:  Cancer Res       Date:  2009-07-14       Impact factor: 12.701

6.  Solving the riddle of the bright mismatches: labeling and effective binding in oligonucleotide arrays.

Authors:  Felix Naef; Marcelo O Magnasco
Journal:  Phys Rev E Stat Nonlin Soft Matter Phys       Date:  2003-07-16

7.  Development of a novel peptide microarray for large-scale epitope mapping of food allergens.

Authors:  Jing Lin; Ludmilla Bardina; Wayne G Shreffler; Doerthe A Andreae; Yongchao Ge; Julie Wang; Francesca M Bruni; Zhiyan Fu; Youngshin Han; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2009-07-03       Impact factor: 10.793

8.  Bioconductor: open software development for computational biology and bioinformatics.

Authors:  Robert C Gentleman; Vincent J Carey; Douglas M Bates; Ben Bolstad; Marcel Dettling; Sandrine Dudoit; Byron Ellis; Laurent Gautier; Yongchao Ge; Jeff Gentry; Kurt Hornik; Torsten Hothorn; Wolfgang Huber; Stefano Iacus; Rafael Irizarry; Friedrich Leisch; Cheng Li; Martin Maechler; Anthony J Rossini; Gunther Sawitzki; Colin Smith; Gordon Smyth; Luke Tierney; Jean Y H Yang; Jianhua Zhang
Journal:  Genome Biol       Date:  2004-09-15       Impact factor: 13.583

Review 9.  Diversity considerations in HIV-1 vaccine selection.

Authors:  Brian Gaschen; Jesse Taylor; Karina Yusim; Brian Foley; Feng Gao; Dorothy Lang; Vladimir Novitsky; Barton Haynes; Beatrice H Hahn; Tanmoy Bhattacharya; Bette Korber
Journal:  Science       Date:  2002-06-28       Impact factor: 47.728

10.  Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2.

Authors:  Morgane Rolland; Paul T Edlefsen; Brendan B Larsen; Sodsai Tovanabutra; Eric Sanders-Buell; Tomer Hertz; Allan C deCamp; Chris Carrico; Sergey Menis; Craig A Magaret; Hasan Ahmed; Michal Juraska; Lennie Chen; Philip Konopa; Snehal Nariya; Julia N Stoddard; Kim Wong; Hong Zhao; Wenjie Deng; Brandon S Maust; Meera Bose; Shana Howell; Adam Bates; Michelle Lazzaro; Annemarie O'Sullivan; Esther Lei; Andrea Bradfield; Grace Ibitamuno; Vatcharain Assawadarachai; Robert J O'Connell; Mark S deSouza; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Merlin L Robb; Jason S McLellan; Ivelin Georgiev; Peter D Kwong; Jonathan M Carlson; Nelson L Michael; William R Schief; Peter B Gilbert; James I Mullins; Jerome H Kim
Journal:  Nature       Date:  2012-09-10       Impact factor: 49.962

View more
  11 in total

1.  Quantification of the epitope diversity of HIV-1-specific binding antibodies by peptide microarrays for global HIV-1 vaccine development.

Authors:  Kathryn E Stephenson; George H Neubauer; Ulf Reimer; Nikolaus Pawlowski; Tobias Knaute; Johannes Zerweck; Bette T Korber; Dan H Barouch
Journal:  J Immunol Methods       Date:  2014-11-15       Impact factor: 2.303

Review 2.  Applications of Peptide Microarrays in Autoantibody, Infection, and Cancer Detection.

Authors:  Carsten Grötzinger
Journal:  Methods Mol Biol       Date:  2023

3.  Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques.

Authors:  Smita S Iyer; Sailaja Gangadhara; Blandine Victor; Xiaoying Shen; Xuemin Chen; Rafiq Nabi; Sudhir P Kasturi; Michael J Sabula; Celia C Labranche; Pradeep B J Reddy; Georgia D Tomaras; David C Montefiori; Bernard Moss; Paul Spearman; Bali Pulendran; Pamela A Kozlowski; Rama Rao Amara
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

4.  Bayesian hierarchical modeling for subject-level response classification in peptide microarray immunoassays.

Authors:  Gregory Imholte; Raphael Gottardo
Journal:  Biometrics       Date:  2016-04-08       Impact factor: 2.571

5.  Chimeric peptide constructs comprising linear B-cell epitopes: application to the serodiagnosis of infectious diseases.

Authors:  Yudong Lu; Zhong Li; Huan Teng; Hongke Xu; Songnan Qi; Jian'an He; Dayong Gu; Qijun Chen; Hongwei Ma
Journal:  Sci Rep       Date:  2015-08-21       Impact factor: 4.379

6.  Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV.

Authors:  Mario Roederer; Brandon F Keele; Stephen D Schmidt; Rosemarie D Mason; Hugh C Welles; Will Fischer; Celia Labranche; Kathryn E Foulds; Mark K Louder; Zhi-Yong Yang; John-Paul M Todd; Adam P Buzby; Linh V Mach; Ling Shen; Kelly E Seaton; Brandy M Ward; Robert T Bailer; Raphael Gottardo; Wenjuan Gu; Guido Ferrari; S Munir Alam; Thomas N Denny; David C Montefiori; Georgia D Tomaras; Bette T Korber; Martha C Nason; Robert A Seder; Richard A Koup; Norman L Letvin; Srinivas S Rao; Gary J Nabel; John R Mascola
Journal:  Nature       Date:  2013-12-18       Impact factor: 49.962

7.  Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccines.

Authors:  Shixia Wang; Te-Hui Chou; Anthony Hackett; Veronica Efros; Yan Wang; Dong Han; Aaron Wallace; Yuxin Chen; Guangnan Hu; Shuying Liu; Paul Clapham; James Arthos; David Montefiori; Shan Lu
Journal:  Hum Vaccin Immunother       Date:  2017-09-21       Impact factor: 3.452

8.  Epitope-Specific Antibody Responses to a Plasmodium falciparum Subunit Vaccine Target in a Malaria-Endemic Population.

Authors:  DeAnna J Friedman-Klabanoff; Mark A Travassos; Olukemi O Ifeonu; Sonia Agrawal; Amed Ouattara; Andrew Pike; Jason A Bailey; Matthew Adams; Drissa Coulibaly; Kirsten E Lyke; Matthew B Laurens; Shannon Takala-Harrison; Bourema Kouriba; Abdoulaye K Kone; Ogobara K Doumbo; Jigar J Patel; Mahamadou A Thera; Philip L Felgner; John C Tan; Christopher V Plowe; Andrea A Berry
Journal:  J Infect Dis       Date:  2021-06-04       Impact factor: 5.226

9.  Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial.

Authors:  Raphael Gottardo; Robert T Bailer; Bette T Korber; S Gnanakaran; Joshua Phillips; Xiaoying Shen; Georgia D Tomaras; Ellen Turk; Gregory Imholte; Larry Eckler; Holger Wenschuh; Johannes Zerweck; Kelli Greene; Hongmei Gao; Phillip W Berman; Donald Francis; Faruk Sinangil; Carter Lee; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Jaranit Kaewkungwal; Punnee Pitisuttithum; James Tartaglia; Merlin L Robb; Nelson L Michael; Jerome H Kim; Susan Zolla-Pazner; Barton F Haynes; John R Mascola; Steve Self; Peter Gilbert; David C Montefiori
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

10.  Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial.

Authors:  Paul T Edlefsen; Morgane Rolland; Tomer Hertz; Sodsai Tovanabutra; Andrew J Gartland; Allan C deCamp; Craig A Magaret; Hasan Ahmed; Raphael Gottardo; Michal Juraska; Connor McCoy; Brendan B Larsen; Eric Sanders-Buell; Chris Carrico; Sergey Menis; Gustavo H Kijak; Meera Bose; Miguel A Arroyo; Robert J O'Connell; Sorachai Nitayaphan; Punnee Pitisuttithum; Jaranit Kaewkungwal; Supachai Rerks-Ngarm; Merlin L Robb; Tatsiana Kirys; Ivelin S Georgiev; Peter D Kwong; Konrad Scheffler; Sergei L Kosakovsky Pond; Jonathan M Carlson; Nelson L Michael; William R Schief; James I Mullins; Jerome H Kim; Peter B Gilbert
Journal:  PLoS Comput Biol       Date:  2015-02-03       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.